Home Ariad shares fall as it cuts revenue guidance
 

Keywords :   


Ariad shares fall as it cuts revenue guidance

2015-12-12 15:42:31| Biotech - Topix.net

Shares of Ariad Pharmaceuticals fell Friday after it cut revenue guidance as it continues to negotiate with French regulators over the price of its leukemia treatment, Iclusig. The Cambridge, Massachusetts-based developer of cancer treatments said that it previously expected to reach an agreement by the end of the year, but it now expects negotiations to continue into 2016.

Tags: fall revenue shares guidance

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 24
05.10Hurricane Kirk Wind Speed Probabilities Number 24
05.10Hurricane Kirk Forecast Advisory Number 24
05.10Hurricane Kirk Public Advisory Number 24
05.10Summary for Hurricane Kirk (AT2/AL122024)
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 12
More »